Red light therapy device Recall: Mito Super Mobile
Announced 2026-06-24 · FDA
The FDA is recalling the Mito Red Light, Super Mobile near-infrared therapy device because its lithium-ion battery may malfunction and cause a fire. The recall covers all serial numbers and no UDI, and the device was distributed worldwide including nationwide in the U.S. No corrective action is specified in the recall notice.
| Brand | MITO RED LIGHT INC |
|---|---|
| Product | Mito Red Light, Super Mobile |
| Reason | The near-infrared therapy device contains a lithium-ion battery that may malfunction, causing it to catch fire or burst into flames. |
| Severity | moderate |
| Distribution | Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NL, NM, NV, NY, OH, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV and the countries of Australia, Canada, China, Japan, New Zealand, Spain, Switzerland, United Arab Emirates, United Kingdom. |
| Agency | FDA |
| Recall / campaign no. | All Serial/Lot numbers/No UDI |
WHAT YOU SHOULD DO
- Stop using the device and unplug it immediately.
- Do not charge or attempt to repair the device; keep it away from heat and flammable materials.
- Contact the manufacturer for instructions on return, disposal, or replacement.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.